In line with these ex vivo data, in vitro experiments showed that AnxA1-mediated signals effectively down-modulated galectin-3 expression in macrophages isolated from NASH livers (Fig. 7). Here, LGALS3 is linked to metabolic dysfunction-associated steatohepatitis.